Mishima Yuta, Wang Changshan, Miyagi Satoru, Saraya Atsunori, Hosokawa Hiroyuki, Mochizuki-Kashio Makiko, Nakajima-Takagi Yaeko, Koide Shuhei, Negishi Masamitsu, Sashida Goro, Naito Taku, Ishikura Tomoyuki, Onodera Atsushi, Nakayama Toshinori, Tenen Daniel G, Yamaguchi Naoto, Koseki Haruhiko, Taniuchi Ichiro, Iwama Atsushi
1] Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan [2] Department of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan [3] JST, CREST, 7 Gobancho, Chiyoda-ku, Tokyo 102-0076, Japan [4] Cancer Science Institute, National University of Singapore, and Harvard Stem Cell Institute, Harvard Medical School, 3 Blackfan Circle, Boston, Massachusetts 02115, USA.
1] Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan [2] JST, CREST, 7 Gobancho, Chiyoda-ku, Tokyo 102-0076, Japan.
Nat Commun. 2014 Dec 18;5:5872. doi: 10.1038/ncomms6872.
During T-cell development, Cd8 expression is controlled via dynamic regulation of its cis-regulatory enhancer elements. Insufficiency of enhancer activity causes variegated Cd8 expression in CD4(+)CD8(+) double-positive (DP) thymocytes. Brd1 is a subunit of the Hbo1 histone acetyltransferase (HAT) complex responsible for acetylation of histone H3 at lysine 14 (H3K14). Here we show that deletion of Brd1 in haematopoietic progenitors causes variegated expression of Cd8, resulting in the appearance of CD4(+)CD8(-)TCRβ(-/low) thymocytes indistinguishable from DP thymocytes in their properties. Biochemical analysis confirms that Brd1 forms a HAT complex with Hbo1 in thymocytes. ChIP analysis demonstrates that Brd1 localizes at the known enhancers in the Cd8 genes and is responsible for acetylation at H3K14. These findings indicate that the Brd1-mediated HAT activity is crucial for efficient activation of Cd8 expression via acetylation at H3K14, which serves as an epigenetic mark that promotes the recruitment of transcription machinery to the Cd8 enhancers.
在T细胞发育过程中,Cd8的表达通过其顺式调控增强子元件的动态调节来控制。增强子活性不足会导致CD4(+)CD8(+)双阳性(DP)胸腺细胞中Cd8表达呈现斑驳状态。Brd1是Hbo1组蛋白乙酰转移酶(HAT)复合物的一个亚基,负责组蛋白H3赖氨酸14位点(H3K14)的乙酰化。在此我们表明,造血祖细胞中Brd1的缺失会导致Cd8表达呈现斑驳状态,从而产生CD4(+)CD8(-)TCRβ(-/low)胸腺细胞,其特性与DP胸腺细胞难以区分。生化分析证实,Brd1在胸腺细胞中与Hbo1形成HAT复合物。染色质免疫沉淀分析表明,Brd1定位于Cd8基因的已知增强子处,并负责H3K14位点的乙酰化。这些发现表明,Brd1介导的HAT活性对于通过H3K14位点的乙酰化有效激活Cd8表达至关重要,H3K14乙酰化作为一种表观遗传标记,促进转录机制募集到Cd8增强子上。